Clinical Trials Directory

Trials / Completed

CompletedNCT00538629

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

NON INTERVENTIONAL STUDY (NIS) IN PATIENTS WITH BIPOLAR DISCORDER (MANIC OR MIXED EPISODES) AND SCHIZOPHRENIA UNDERGOING TREATEMENT WITH ZELDOX

Status
Completed
Phase
—
Study type
Observational
Enrollment
471 (actual)
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Investigation of the impact of Zeldox on metabolic parametres in patients with bipolar disorder or with schizophrenia and impact of the treatment for the quality of life

Detailed description

observational survey consecutive patient sampling

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention
OTHERno interventionno intervention

Timeline

Start date
2007-10-16
Primary completion
2008-04-30
Completion
2008-04-30
First posted
2007-10-02
Last updated
2022-11-18
Results posted
2009-08-19

Source: ClinicalTrials.gov record NCT00538629. Inclusion in this directory is not an endorsement.